Learning from the past to plan for the future Virginia Berridge Centre for History in Public Health, London School of Hygiene and Tropical Medicine, University.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

Open Days 2007: 2nd EU-China Regional Policy Seminar, 8 October 2007 "Workshop 2: Multi-level governance and partnership in regional policy" Presentation.
1 Seminar on urban-rural linkages fostering social cohesion in Europe Brussels, 2 July 2009 EUROPEAN COMMISSION DG Employment, Social Affairs and Equal.
Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.
Identifying Europe’s information needs for effective drug policy Conference overview Wolfgang Götz, EMCDDA.
Experiences of Drug Consumption Rooms in Europe
Alcohol & Substance Abuse Prevention. Aim of the ASAP Programme – To reduce the harm caused by alcohol and drugs throughout the Association Educate Raise.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
Changing the AER for the 21 st Century. Changing the AER for the 21st Century, short version Services for better decision-making and visibility, putting.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
South-East European Cooperation Process ROMANIA South-East European Cooperation Process (SEECP)
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Annual report 2010: the state of the drugs problem in Europe.
Marina Kuzman, MD, PhD Croatian National Institute of Public Health National Drug Prevention and Information System in the Republic of Croatia - impact.
Components of a national drug prevention system Ms. UNODC.
Elisad history and goals Thomas ROUAULT. Marianne VAN DER HEYDEN 11th Elisad annual meeting Lisbon. EMCDDA 4-5 November 1999.
Feeling EUROPE Foundation and beyond?. Feeling EUROPE Foundation Europe’s merits (postmodern era): peace, security and prosperity single market (incl.
DISABILITY- STATISTICS BOTSWANA Diemo Motlapele Senior Statistician/Health Information Manager - Statistics.
STRATEGY OF DRUG AND HIV/AIDS PREVENTION IN THE CITY AND DISTRICTS OF TALLINN Ene Tomberg Department of Social Welfare and Health Care of Tallinn.
KnowledgeManagement Social Change SYNERGIA. and for KnowledgeManagement SYNERGIA.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
ELDD Reflection – past, present and future 29th Meeting of the Scientific Committee, 18 Nov 2008.
Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.
The impact of treatment demand data on policy and practice Hamish Sinclair & Jean Long Drug Misuse Research Division Health Research Board Ireland Richard.
04_DirectorReport_PCC/1 9/2004 Rita Kabra_/1 Access to essential medicines for Maternal and Newborn Health Dr Rita Kabra Making Pregnancy Safer WHO/EDM.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Promoting excellence:
ENVIRONMENT & HEALTH INDICATORS FOR EUROPE: A PILOT STUDY OF INDICATORS OF AIR POLLUTION & HEALTH D Dalbokova, 1 M Sadeh, 2 M Krzyzanowski, 1 P Wilkinson.
The History of the Social Survey - the Social Survey in History Anne Sofie Fink Danish Data Archives.
Gender : Topics  Definition  What kind of policy ?  Bureau for Gender Equality  Monitoring progress  Gender and the ILO Staff Union.
THEMATIC WORKSHOP B 9-11 MAY 2011 TURIN Offering an Integrated Response to the Social Demand for Education and Training.
WOMEN PROFILE AND GENDER ANALYSIS IN TREATMENT DATA UNODC DATA.
Situation Analysis. 2 Policy and planning Key messages Situation analysis is more than burden of disease (BoD) Also include SDH, population expectations.
Background information about ESPAD The European School Survey Project on Alcohol and Other Drugs.
The Launch of RUN Recovered Users Network Boro Goic, Chair of RUN.
6 June 2007 Dias 1 Peter Furu DBL – Centre for Health Research and Development, Charlottenlund, Denmark WHO Collaborating Centre for Health and Environment.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Prisoners Last updated: November 2015.
Making a REAL difference REAL: the voice of language teachers in Europe Decision-makers.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
Successes and Challenges of Integrating Quality Improvement in HIV Prevention: Results of the Quality Action's mixed method evaluation Christiana Nöstlinger.
Mădălina Dobrescu European Institute, LSE 1 May 2013.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
Evaluation of Action Plan Turkish Monitoring Center for Drugs and Drug Addiction TUBIM.
Exploitation means to use and benefit from something. For Erasmus+ this means maximising the potential of the funded activities, so that the results are.
National Bureau for Drug Prevention , Warsaw.
Prisoners Last updated: November 2015.
Dr Charmaine Gauci Superintendent of Public Health/Director General PH
Figure 1 Growth of nurse education programme since 1991 (SN, B. N
Figure 1. Programme provisions, eligibility, evaluation period and geographical coverage of programme over time From: Impact evaluation of free delivery.
ESPON post 2013 Programme Kristīne Rasiņa
Welcome to the Institute of Psychiatry, King’s College London
SCD Scientific Partners and Documentation
Note: average (larger bar) and median are shown
YOUTH Programme Presentation
بسم الله الرحمن الرحیم.
ESTICOM Symposium 23 July 2018
Julian Hiebl, labour market expert
Ex-post evaluation of the ESF
Raising the bar Meeting Europe’s future challenges
Эмийн гаж нөлөөг бүртгэн мэдээлэх, ач холбогдол
Bente Lauridsen Deputy Chair of the Regional Council
EMCDDA Work programme: outputs and communication
Basic principles Overview on proposals Clustering proposals
EU Drugs Action Plan: Guidelines and standards
Presentation transcript:

Learning from the past to plan for the future Virginia Berridge Centre for History in Public Health, London School of Hygiene and Tropical Medicine, University of London

Outline  1. The past of European research coordination  2. The present situation  3.The future: what needs?

The past: twenty years ago  Researching drug research in Europe

EMCDDA was interested  ‘an important document for the European Monitoring Centre for Drugs and Drug Addiction which is in a stage of being established.’  Hilde Van Lindt programme coordinator EMCDDA,Brussels  15 July 1993.

The present : twenty years later  Common monitoring and standardisation  The European view  Convergence in ideas and policies?  ‘ the European Union is now mainly a single voice at international meetings, with a strong and explicit harm reduction tone… ’Peter Reuter,2009

What future needs?  Taking convergence further?  Defining drugs  The demands of evidence and policy  Integration of qualitative research  Looking back to look forward?

The demands of evidence and policy  The rational model  Enlightenment?  The limestone effect  Political constraints  Research on how research is used.

Integration of qualitative research  Moving beyond epidemiology  Integrating quantitative and qualitative  National reporting  Training  Outreach

Looking back : ten years ago

Looking back to look forward  Failure to learn from past experience  Policy transfer- local/ national/ Europe /international  Witness seminars, interviews and archives  History from below and from above :pressure groups and policy makers.